December 28, 2016: Hearing takeover rumors about biotechnology firm Intercept Pharmaceuticals. The rumor is that Novartis could be a potential acquirer. Can not find the source of the rumors. StreetInsider asked an Intercept Pharmaceuticals spokesperson about the rumor and the company said it will not comment on M&A speculation.
Intercept Pharmaceuticals Stock Chart
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic underserved liver diseases.